1. Next generation FIX muteins with FVIII‐independent activity for alternative treatment of hemophilia A. (15th October 2014) Authors: Quade‐Lyssy, P.; Abriss, D.; Milanov, P.; Ungerer, C.; Königs, C.; Seifried, E.; Schüttrumpf, J. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 11(2014:Nov.) Page Start: 1861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Oral gene therapy for hemophilia B using chitosan‐formulated FIX mutants. (June 2014) Authors: Quade‐Lyssy, P.; Milanov, P.; Abriss, D.; Ungerer, C.; Königs, C.; Seifried, E.; Schüttrumpf, J. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 6(2014:Jun.) Page Start: 932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗